{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T01:56:52Z","timestamp":1755223012822,"version":"3.43.0"},"reference-count":50,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["European J of Haematology"],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Fludarabine, busulfan, and anti\u2010T\u2010lymphocyte globulin (FLUBU3+ATLG) reduced\u2010intensity conditioning is an established preparative regimen for allogeneic haematopoietic stem cell transplantation in older patients with myeloid malignancy. We examined its modern\u2010day performance in 175 sequentially treated patients on our national programme. Overall survival was 72.4% at 2\u2009years (95% CI 64.6%\u201378.6%) with a cumulative incidence of non\u2010relapse mortality of 11%. The cumulative 2\u2010year relapse incidence was 27% (95% CI 22.8%\u201337.6%) and was partially ameliorated by chronic graft\u2010versus\u2010host disease (HR 0.35, 95% CI 0.12\u20130.98, <jats:italic>p\u2009=\u20090.02<\/jats:italic>). Mixed donor chimerism was observed in 51.5% beyond day 90, but relapse was significantly reduced in these patients by adopting a pre\u2010emptive donor lymphocyte infusion (DLI) strategy (HR 0.22, 95% CI 0.07\u20130.69, <jats:italic>p\u2009=\u20090.005<\/jats:italic>). The use of DLI as part of post\u2010relapse salvage was also effective, with an improved median survival duration of 6\u2009months in recipients (HR 0.43, 95% CI 0.18\u20130.98, <jats:italic>p\u2009=\u20090.01<\/jats:italic>). Outcomes in patients &gt;\u200965\u2009years and a limited cohort &gt;\u200970\u2009years are encouraging and compare favourably to published survival results using alternate reduced\u2010intensity regimens. FLUBU3+ATLG, supported by modern supportive care and a pre\u2010emptive DLI strategy, is well tolerated by older patients across a spectrum of myeloid disease with modest toxicity and favourable long\u2010term outcomes.<\/jats:p>","DOI":"10.1111\/ejh.14417","type":"journal-article","created":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T12:33:13Z","timestamp":1743337993000},"page":"36-45","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Allogeneic Haematopoietic Stem Cell Transplantation Using Reduced\u2010Intensity Fludarabine, Busulfan and Anti\u2010T\u2010Lymphocyte Globulin With Strategic Donor Lymphocyte Infusion in Older Patients With Myeloid Malignancy"],"prefix":"10.1111","volume":"115","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5704-7895","authenticated-orcid":false,"given":"Chris","family":"Armstrong","sequence":"first","affiliation":[{"name":"National Adult Stem Cell Transplant Centre, St. James' Hospital  Dublin Ireland"},{"name":"Trinity College Dublin The University of Dublin  Dublin Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eibhlin","family":"Conneally","sequence":"additional","affiliation":[{"name":"National Adult Stem Cell Transplant Centre, St. James' Hospital  Dublin Ireland"},{"name":"Trinity College Dublin The University of Dublin  Dublin Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Flynn","sequence":"additional","affiliation":[{"name":"National Adult Stem Cell Transplant Centre, St. James' Hospital  Dublin Ireland"},{"name":"Trinity College Dublin The University of Dublin  Dublin Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Browne","sequence":"additional","affiliation":[{"name":"National Adult Stem Cell Transplant Centre, St. James' Hospital  Dublin Ireland"},{"name":"Trinity College Dublin The University of Dublin  Dublin Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mairead Ni","family":"Chonghaile","sequence":"additional","affiliation":[{"name":"National Adult Stem Cell Transplant Centre, St. James' Hospital  Dublin Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmel Ann","family":"Galligan","sequence":"additional","affiliation":[{"name":"National Adult Stem Cell Transplant Centre, St. James' Hospital  Dublin Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayley","family":"Foy\u2010Stones","sequence":"additional","affiliation":[{"name":"National Adult Stem Cell Transplant Centre, St. James' Hospital  Dublin Ireland"},{"name":"Trinity College Dublin The University of Dublin  Dublin Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Gardiner","sequence":"additional","affiliation":[{"name":"National Adult Stem Cell Transplant Centre, St. James' Hospital  Dublin Ireland"},{"name":"Trinity College Dublin The University of Dublin  Dublin Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Greg","family":"Lee","sequence":"additional","affiliation":[{"name":"National Adult Stem Cell Transplant Centre, St. James' Hospital  Dublin Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina","family":"Orfali","sequence":"additional","affiliation":[{"name":"National Adult Stem Cell Transplant Centre, St. James' Hospital  Dublin Ireland"},{"name":"Trinity College Dublin The University of Dublin  Dublin Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2025,3,27]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41409\u2010023\u201001943\u20103"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704384"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-07-234880"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.29163"},{"key":"e_1_2_10_6_1","first-page":"578","article-title":"Impact of Donor Age on Allogeneic Hematopoietic Cell Transplantation Outcomes in Older Adults With Acute Myeloid Leukemia","volume":"29","author":"Abid M. B.","year":"2023","journal-title":"Transplantation and Cellular Therapy"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(19)30157-7"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-020-00923-0"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2013.204"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41409\u2010017\u20100043\u2010y"},{"key":"e_1_2_10_11_1","first-page":"S549","article-title":"ATG Included in the Fludarabin\u2010Busulfan Protocol for Sibling Donor HSCT Is Associated to Relapse and Lower Survival","volume":"49","author":"Remberger M.","year":"2014","journal-title":"Bone Marrow Transplantation"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000487"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1071268"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000021571"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102022\u2010171463"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26620"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41409\u2010022\u201001646\u20101"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019001266"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102018\u201099\u2010116795"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V124.21.545.545"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2017.07.007"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-023-05276-5"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.11.6053"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-021-01464-x"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2021.06.029"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-019-0536-y"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.7"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2017015222"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021004435"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2021000257"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.02724"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.03380"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2021.03.028"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022016916"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2008.12.497"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277\u2010015\u20102349\u20104"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2012.11.273"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102022\u2010168678"},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V126.23.736.736"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2021.08.007"},{"key":"e_1_2_10_41_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404886"},{"key":"e_1_2_10_42_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.591363"},{"key":"e_1_2_10_43_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27252"},{"key":"e_1_2_10_44_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021005035"},{"key":"e_1_2_10_45_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2215943"},{"key":"e_1_2_10_46_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16142567"},{"key":"e_1_2_10_47_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-022-01908-y"},{"key":"e_1_2_10_48_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1917635"},{"key":"e_1_2_10_49_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021012021"},{"key":"e_1_2_10_50_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.00958"},{"key":"e_1_2_10_51_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41409\u2010021\u201001515\u20103"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ejh.14417","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T09:30:23Z","timestamp":1754904623000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ejh.14417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,27]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["10.1111\/ejh.14417"],"URL":"https:\/\/doi.org\/10.1111\/ejh.14417","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"type":"print","value":"0902-4441"},{"type":"electronic","value":"1600-0609"}],"subject":[],"published":{"date-parts":[[2025,3,27]]},"assertion":[{"value":"2025-01-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}